Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Open in Screener

CBLL

Ceribell Inc.

Oct 22 • 04:00PM ET

26.35

Dollar change -0.70
Percentage change -2.59	%

Healthcare • Medical Devices • USA • NASD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	61.51%	Shs Outstand	34.02M	Perf Week	3.21%
Market Cap	896.43M	Forward P/E	-	EPS next Y	-	Insider Trans	3.04%	Shs Float	13.09M	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	29.61%	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	23.00 - 27.71	Perf YTD	5.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-4.91%	Beta	-
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	74.47%	Gross Margin	-	52W Low	14.57%	ATR (14)	1.54
Dividend Ex-Date	-	Current Ratio	-	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	4.95% -
Employees	229	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-	Payout	-	Rel Volume	0.44	Prev Close	27.05
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	843.64K	Price	26.35
SMA20	0.85%	SMA50	0.85%	SMA200	0.85%	Trades		Volume	397,532	Change	-2.59%

Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	Loading…
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TPG GP A, LLC	10% Owner	Oct 15 '24	Buy	17.00	380,268	6,464,556	3,967,422	Oct 17 04:14 PM
Tammenoms Bakker Juliet	Director	Oct 15 '24	Buy	17.00	237,234	4,032,978	2,475,110	Oct 16 04:18 PM

Open in Screener

RXST

RxSight Inc

Oct 22 • 04:00PM ET

50.29

Dollar change -0.23
Percentage change -0.46	%

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO SCHA VTWO DWAS VHT XHE NUSC

Index	RUT	P/E	-	EPS (ttm)	-1.01	Insider Own	5.11%	Shs Outstand	39.68M	Perf Week	1.37%
Market Cap	2.00B	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-6.60%	Shs Float	37.66M	Perf Month	-2.46%
Income	-36.77M	PEG	-	EPS next Q	-0.23	Inst Own	82.59%	Short Float	5.99%	Perf Quarter	5.13%
Sales	115.18M	P/S	17.33	EPS this Y	42.04%	Inst Trans	-0.37%	Short Ratio	4.67	Perf Half Y	-8.43%
Book/sh	6.95	P/B	7.24	EPS next Y	35.67%	ROA	-14.69%	Short Interest	2.26M	Perf Year	104.10%
Cash/sh	5.88	P/C	8.55	EPS next 5Y	-	ROE	-17.01%	52W Range	20.66 - 66.54	Perf YTD	24.73%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-12.86%	52W High	-24.42%	Beta	1.19
Dividend TTM	-	Quick Ratio	13.34	Sales past 5Y	201.89%	Gross Margin	66.26%	52W Low	143.42%	ATR (14)	1.70
Dividend Ex-Date	-	Current Ratio	14.33	EPS Y/Y TTM	49.16%	Oper. Margin	-36.78%	RSI (14)	49.28	Volatility	2.67% 3.42%
Employees	374	Debt/Eq	0.04	Sales Y/Y TTM	71.90%	Profit Margin	-31.93%	Recom	1.00	Target Price	64.50
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	60.48%	Payout	-	Rel Volume	0.48	Prev Close	50.52
Sales Surprise	7.92%	EPS Surprise	28.22%	Sales Q/Q	67.65%	Earnings	Aug 05 AMC	Avg Volume	483.25K	Price	50.29
SMA20	2.01%	SMA50	-3.23%	SMA200	-4.38%	Trades		Volume	231,847	Change	-0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36
Apr-13-23	Initiated	Oppenheimer	Outperform	$23
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$20 → $14
Apr-08-22	Initiated	Needham	Buy	$18

Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
09:55AM	Loading…
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
02:40PM	Loading…
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	Loading…
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire) +6.08%
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)
11:09AM	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:36AM	Q4 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:38PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Jan-19-24 05:01PM	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc (GuruFocus.com)
Jan-12-24 03:16PM	3 Stocks to Buy BEFORE They Become Household Names (InvestorPlace)
Jan-09-24 06:19PM	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average (Zacks)
Jan-07-24 10:00AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance (GlobeNewswire)
Dec-27-23 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-15-23 09:30AM	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-12-23 10:26AM	RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 07:42AM	Q3 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM	RxSight, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 09:00AM	RxSight, Inc. Educational and Product Announcements for AAO 2023 (GlobeNewswire)
Oct-26-23 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) -5.43%
Sep-07-23 09:35AM	RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-23-23 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-22-23 05:20PM	Has Alcon (ALC) Outpaced Other Medical Stocks This Year? (Zacks)
Aug-18-23 09:23AM	The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight (Zacks)
Aug-17-23 08:37AM	3 Medical Device Stocks With Potential to Fight Deflation Risk (Zacks)
Aug-08-23 08:44AM	RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:21AM	Q2 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023 (GlobeNewswire)
Jun-30-23 08:31AM	Strength Seen in RxSight, Inc. (RXST): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Jun-27-23 08:38AM	Alphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
Jun-18-23 10:53AM	Investors in RxSight (NASDAQ:RXST) have seen respectable returns of 79% over the past year (Simply Wall St.)
May-10-23 07:52AM	Q1 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-03-23 10:00AM	Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
May-02-23 10:02AM	Will RxSight, Inc. (RXST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-26-23 06:33PM	2 Strong Buy Stocks Oppenheimer Predicts Will Surge at Least 30% (TipRanks)
04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
Apr-25-23 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023 (GlobeNewswire)
Apr-24-23 04:05PM	Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Apr-18-23 11:26AM	RxSight, Inc. (NASDAQ:RXST) Not Lagging Industry On Growth Or Pricing (Simply Wall St.)
Apr-11-23 12:00PM	Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy (Zacks)
Apr-05-23 04:05PM	RxSight, Inc. to Present at the Needham Healthcare Conference (GlobeNewswire)
Mar-13-23 09:55AM	How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69% (Zacks)
Mar-08-23 07:21AM	RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:23AM	Q4 2022 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
05:16AM	RxSight, Inc.'s (NASDAQ:RXST) biggest owners are individual investors who got richer after stock soared 14% last week (Simply Wall St.)
Mar-06-23 04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +12.96%
Feb-28-23 04:05PM	RxSight, Inc. to Present at the Oppenheimer Healthcare Conference (GlobeNewswire)
Feb-21-23 04:05PM	RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-14-23 04:05PM	RxSight, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock (GlobeNewswire)
Feb-08-23 12:45AM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -7.70%
Feb-07-23 04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-09-23 08:56AM	Investing in RxSight (NASDAQ:RXST) a year ago would have delivered you a 12% gain (Simply Wall St.)
Jan-08-23 04:00PM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results (GlobeNewswire)
Dec-31-22 06:15AM	RxSight, Inc. (NASDAQ:RXST) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-28-22 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-22 09:40AM	Has IntraCellular Therapies (ITCI) Outpaced Other Medical Stocks This Year? (Zacks) +5.33%
Dec-06-22 09:40AM	Is RxSight (RXST) Stock Outpacing Its Medical Peers This Year? (Zacks) -7.66%
Dec-02-22 09:55AM	Does RxSight, Inc. (RXST) Have the Potential to Rally 43% as Wall Street Analysts Expect? (Zacks)
Nov-16-22 09:55AM	Wall Street Analysts Predict a 45% Upside in RxSight, Inc. (RXST): Here's What You Should Know (Zacks)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Goldshleger Ilya	See remarks	Oct 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 22 08:17 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Sale	49.68	3,100	154,001	42,246	Oct 22 08:17 PM
ILYA GOLDSHLEGER	Officer	Oct 22 '24	Proposed Sale	49.68	3,100	154,001		Oct 22 04:16 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Sale	50.09	3,105	155,533	42,246	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Sale	49.78	3,100	154,318	42,246	Oct 18 05:23 PM
ILYA GOLDSHLEGER	Officer	Oct 18 '24	Proposed Sale	50.09	3,105	155,533		Oct 18 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 16 '24	Proposed Sale	49.78	3,100	154,317		Oct 16 04:16 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Sale	50.19	3,100	155,594	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Sale	50.09	3,100	155,268	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Sale	48.82	3,105	151,596	42,246	Oct 15 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 14 '24	Proposed Sale	50.09	3,100	155,268		Oct 15 08:23 AM
ILYA GOLDSHLEGER	Officer	Oct 11 '24	Proposed Sale	50.19	3,100	155,593		Oct 11 04:17 PM
ILYA GOLDSHLEGER	Officer	Oct 10 '24	Proposed Sale	48.82	3,105	151,595		Oct 10 04:11 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Sale	48.26	3,100	149,612	42,246	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Sale	48.01	3,100	148,824	42,246	Oct 08 06:00 PM
ILYA GOLDSHLEGER	Officer	Oct 08 '24	Proposed Sale	48.26	3,100	149,612		Oct 08 04:19 PM
ILYA GOLDSHLEGER	Officer	Oct 04 '24	Proposed Sale	48.01	3,100	148,824		Oct 04 04:23 PM
Thunen Shelley B	See remarks	Oct 01 '24	Option Exercise	16.00	15,000	240,000	45,443	Oct 02 04:11 PM
Thunen Shelley B	See remarks	Oct 01 '24	Sale	48.45	15,000	726,730	30,443	Oct 02 04:11 PM
SHELLEY B THUNEN	Officer	Oct 01 '24	Proposed Sale	48.45	15,000	726,729		Oct 01 04:24 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Option Exercise	15.08	3,105	46,823	45,351	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Sale	49.29	3,105	153,054	42,246	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Sale	49.02	3,100	151,947	42,246	Sep 30 08:05 PM
ILYA GOLDSHLEGER	Officer	Sep 30 '24	Proposed Sale	49.02	3,100	151,946		Sep 30 04:14 PM
ILYA GOLDSHLEGER	Officer	Sep 26 '24	Proposed Sale	49.29	3,105	153,054		Sep 26 04:09 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Sale	53.19	3,100	164,901	42,246	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Sale	52.67	3,100	163,263	42,246	Sep 23 06:48 PM
ILYA GOLDSHLEGER	Officer	Sep 23 '24	Proposed Sale	52.67	3,100	163,263		Sep 23 04:08 PM
ILYA GOLDSHLEGER	Officer	Sep 20 '24	Proposed Sale	53.19	3,100	164,901		Sep 20 04:08 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 18 04:41 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Sale	56.11	3,100	173,944	42,246	Sep 18 04:41 PM
ILYA GOLDSHLEGER	Officer	Sep 17 '24	Proposed Sale	56.11	3,100	173,943		Sep 17 04:15 PM
Kurtz Ronald M MD	President & CEO	Aug 09 '24	Option Exercise	12.60	9,950	125,355	63,450	Aug 09 05:57 PM
Goldshleger Ilya	See remarks	Aug 05 '24	Sale	39.25	9,000	353,291	42,246	Aug 06 04:19 PM
ILYA GOLDSHLEGER	Officer	Aug 05 '24	Proposed Sale	39.25	9,000	353,290		Aug 05 04:08 PM
Thunen Shelley B	See remarks	Jul 15 '24	Option Exercise	4.34	16,505	71,632	30,443	Jul 16 08:15 PM
Kurtz Ronald M MD	President & CEO	Jul 11 '24	Option Exercise	15.08	13,500	203,604	53,500	Jul 12 07:12 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Option Exercise	15.60	10,000	155,983	23,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.61	10,000	586,055	13,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.77	8,402	493,760	0	Jul 02 04:25 PM
Andrews Julie	Director	Jun 14 '24	Sale	58.00	15,625	906,288	30,287	Jun 17 06:45 PM
Tammenoms Bakker Juliet	Director	May 17 '24	Buy	61.09	5,000	305,456	34,840	May 21 04:11 PM
Goldshleger Ilya	Chief Operating Officer	May 17 '24	Option Exercise	4.04	24,771	100,066	51,246	May 20 04:56 PM
Kurtz Ronald M MD	President & CEO	May 03 '24	Sale	60.15	40,000	2,405,872	764,610	May 06 05:02 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Option Exercise	15.60	10,247	159,836	23,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Sale	52.69	10,000	526,913	13,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	Apr 01 '24	Sale	49.90	20,000	997,946	8,402	Apr 02 04:18 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Option Exercise	15.60	10,000	155,983	23,691	Mar 05 04:05 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Sale	56.37	10,000	563,726	13,691	Mar 05 04:05 PM
Goldshleger Ilya	Chief Operating Officer	Feb 16 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 14 '24	Option Exercise	23.04	5,000	115,200	31,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 16 '24	Sale	55.50	10,000	555,000	26,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Sale	53.50	10,000	535,000	26,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 14 '24	Sale	52.00	5,000	260,000	26,475	Feb 16 05:00 PM
Tammenoms Bakker Juliet	Director	Feb 14 '24	Buy	51.29	4,000	205,153	29,840	Feb 15 04:15 PM
Tammenoms Bakker Juliet	Director	Feb 12 '24	Buy	50.38	4,000	201,520	25,840	Feb 15 04:15 PM
Goldshleger Ilya	Chief Operating Officer	Feb 09 '24	Option Exercise	20.90	10,365	216,598	36,840	Feb 12 06:02 PM
Goldshleger Ilya	Chief Operating Officer	Feb 09 '24	Sale	50.74	10,365	525,939	26,475	Feb 12 06:02 PM
Thunen Shelley B	Chief Financial Officer	Feb 06 '24	Option Exercise	14.95	15,875	237,331	29,566	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 05 '24	Option Exercise	10.38	16,025	166,365	22,816	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 06 '24	Sale	47.47	15,875	753,574	13,691	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 05 '24	Sale	47.02	9,125	429,087	13,691	Feb 07 05:18 PM
LINK WILLIAM J PHD	Director	Feb 01 '24	Sale	49.67	28,250	1,403,120	24,248	Feb 02 04:49 PM
Goldshleger Ilya	Chief Operating Officer	Feb 01 '24	Option Exercise	19.24	7,129	137,181	33,604	Feb 02 04:47 PM
Goldshleger Ilya	Chief Operating Officer	Feb 01 '24	Sale	49.29	7,129	351,411	26,475	Feb 02 04:47 PM
Weinberg Eric	Chief Commercial Officer	Feb 01 '24	Sale	50.00	10,000	500,004	299,978	Feb 02 04:47 PM
Thunen Shelley B	Chief Financial Officer	Jan 26 '24	Option Exercise	13.75	36,272	498,652	38,563	Jan 29 05:36 PM
Thunen Shelley B	Chief Financial Officer	Jan 26 '24	Sale	47.11	31,772	1,496,706	6,791	Jan 29 05:36 PM
Weinberg Eric	Chief Commercial Officer	Jan 22 '24	Sale	48.00	10,000	480,006	309,978	Jan 22 07:50 PM
Goldshleger Ilya	Chief Operating Officer	Jan 22 '24	Option Exercise	18.90	5,000	94,500	31,475	Jan 22 07:48 PM
Goldshleger Ilya	Chief Operating Officer	Jan 22 '24	Sale	48.00	5,000	240,000	26,475	Jan 22 07:48 PM
Maniar Shweta	Director	Jan 18 '24	Sale	45.72	6,399	292,555	12,130	Jan 19 04:01 PM
Goldshleger Ilya	Chief Operating Officer	Jan 09 '24	Option Exercise	18.90	5,000	94,500	31,475	Jan 10 05:29 PM
Goldshleger Ilya	Chief Operating Officer	Jan 09 '24	Sale	47.00	5,000	235,000	26,475	Jan 10 05:29 PM
Weinberg Eric	Chief Commercial Officer	Jan 09 '24	Sale	46.00	10,000	460,000	319,978	Jan 10 05:28 PM
Weinberg Eric	Chief Commercial Officer	Jan 08 '24	Sale	42.00	10,000	420,000	329,978	Jan 09 04:12 PM
Warner Robert Keith	Director	Jan 08 '24	Sale	42.69	23,750	1,013,894	0	Jan 09 04:10 PM
Maniar Shweta	Director	Jan 08 '24	Sale	45.00	6,418	288,810	18,529	Jan 09 04:09 PM
Kurtz Ronald M MD	President & CEO	Jan 08 '24	Sale	44.25	62,500	2,765,631	804,610	Jan 09 04:08 PM
Goldshleger Ilya	Chief Operating Officer	Jan 08 '24	Option Exercise	15.08	15,000	226,200	41,475	Jan 09 04:05 PM
Goldshleger Ilya	Chief Operating Officer	Jan 08 '24	Sale	43.33	15,000	650,000	26,475	Jan 09 04:05 PM
Corley Jesse Anderson	Director	Jan 08 '24	Sale	45.03	2,000	90,059	11,625	Jan 09 04:02 PM
Thunen Shelley B	Chief Financial Officer	Jan 02 '24	Option Exercise	15.60	10,000	155,983	12,291	Jan 03 04:11 PM
Thunen Shelley B	Chief Financial Officer	Jan 02 '24	Sale	39.24	10,000	392,409	2,291	Jan 03 04:11 PM
Kurtz Ronald M MD	President & CEO	Dec 27 '23	Sale	41.09	22,500	924,498	867,110	Dec 29 04:57 PM
Weinberg Eric	Chief Commercial Officer	Dec 22 '23	Sale	40.00	1,285	51,400	339,978	Dec 26 04:11 PM
Goldshleger Ilya	Chief Operating Officer	Dec 22 '23	Option Exercise	15.08	5,000	75,400	31,475	Dec 26 04:10 PM
Goldshleger Ilya	Chief Operating Officer	Dec 22 '23	Sale	40.00	5,000	200,000	26,475	Dec 26 04:10 PM
Goldshleger Ilya	Chief Operating Officer	Dec 18 '23	Option Exercise	14.14	10,937	154,670	37,412	Dec 20 06:07 PM

CBLL

Ceribell Inc.

RXST

RxSight Inc

Upgrade your FINVIZ experience